Skip to main content

Hughes Steven George's Form 4 filing

Avidity Biosciences, Inc. · filed Aug 8, 2025

Accession no.
0001599901-25-000150
Filed
Aug 8, 2025
Trade date
Aug 6, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 4 derivative transactions. Open-market sales total $3.48M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hughes Steven GeorgeCIK 0001747528Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2025Common StockMOption exerciseAcquired+11,283$15.96+$180,076.6884,133Direct
Aug 6, 2025Common StockSSaleDisposed−11,283$42.74F2−$482,235.4272,850Direct
Aug 6, 2025Common StockMOption exerciseAcquired+12,334$6.57+$81,034.3885,184Direct
Aug 6, 2025Common StockSSaleDisposed−12,334$42.74F2−$527,155.1672,850Direct
Aug 6, 2025Common StockMOption exerciseAcquired+6,167$22.47+$138,572.4979,017Direct
Aug 6, 2025Common StockSSaleDisposed−6,167$42.74F2−$263,577.5872,850Direct
Aug 6, 2025Common StockMOption exerciseAcquired+17,667$10.16+$179,496.7290,517Direct
Aug 6, 2025Common StockSSaleDisposed−17,667$42.74F2−$755,087.5872,850Direct
Aug 6, 2025Common StockSSaleDisposed−33,983$42.74F2−$1,452,433.4238,867Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2025Common StockMOption exerciseDisposed−11,283$0.00$073,342Direct
Aug 6, 2025Common StockMOption exerciseDisposed−12,334$0.00$052,417Direct
Aug 6, 2025Common StockMOption exerciseDisposed−6,167$0.00$074,000Direct
Aug 6, 2025Common StockMOption exerciseDisposed−17,667$0.00$075,083Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.15 to $46.44. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 5 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)